OPKO Health, Inc. Equity Method Investment, Summarized Financial Information, Liabilities (Deprecated 2020-01-31)
OPKO Health, Inc. (OPK) had Equity Method Investment, Summarized Financial Information, Liabilities (Deprecated 2020-01-31) of $38.00 million as of 2020-03-31, per its 10-Q filed 2020-05-06.
Discontinued › Notes › Investments › Equity Method Investments and Joint Ventures › Equity Method Investment, Difference Between Carrying Amount and Underlying Equity
us-gaap:EquityMethodInvestmentSummarizedFinancialInformationLiabilities · last filed 2020-05-06
- 2020-03-31: Equity Method Investment, Summarized Financial Information, Liabilities (Deprecated 2020-01-31) $38.00M.
- 2019-12-31: Equity Method Investment, Summarized Financial Information, Liabilities (Deprecated 2020-01-31) $58.40M.
- 2019-09-30: Equity Method Investment, Summarized Financial Information, Liabilities (Deprecated 2020-01-31) $59.90M.
- 2019-06-30: Equity Method Investment, Summarized Financial Information, Liabilities (Deprecated 2020-01-31) $51.90M.
| Period end | Equity Method Investment, Summarized Financial Information, Liabilities (Deprecated 2020-01-31) |
|---|---|
| 2020-03-31 | $38.00M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $58.40M 10-K · filed 2020-03-02 |
| 2019-09-30 | $59.90M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $51.90M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $51.50M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $85.90M 10-K · filed 2019-03-01 |
| 2018-09-30 | $117.20M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $174.60M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $142.70M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $201.80M 8-K · filed 2019-01-29 |
| 2017-09-30 | $203.20M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $194.00M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $201.50M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $205.10M 10-K · filed 2017-03-01 |
| 2016-09-30 | $173.80M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $167.80M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $84.90M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $61.60M 10-K · filed 2016-02-29 |
| 2015-09-30 | $100.30M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $96.70M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $51.00M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $91.50M 10-K · filed 2015-02-27 |
| 2014-09-30 | -$18.80M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $17.70M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $41.20M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $39.20M 10-K · filed 2014-03-03 |
| 2013-09-30 | $39.60M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $33.00M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $15.10M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $12.80M 10-K · filed 2013-03-18 |
| 2012-09-30 | $11.00M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $2.00M 10-Q · filed 2012-08-09 |
| 2011-12-31 | $1.90M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |